SIREN : 822240065
MED-EYES is a French company founded 9 years ago, specialized in the sector Programmation informatique. Based in MONTPELLIER (34000), this company of category PME shows in 2022 a revenue of 132 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2021 | 2019 | 2017 |
|---|---|---|---|---|
| Revenue | 132 474 € | 80 027 € | N/C | N/C |
| Net income | 85 210 € | 55 936 € | 0 € | 0 € |
| EBITDA | 116 399 € | 73 371 € | N/C | N/C |
| Net margin | 64.3% | 69.9% | N/C | N/C |
In 2022, MED-EYES achieves revenue of 132 k€. Over the period 2021-2022, the company shows strong growth with a CAGR (compound annual growth rate) of +65.5%. Vs 2021, growth of +66% (80 k€ -> 132 k€). After deducting consumption (0 €), gross margin stands at 132 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 116 k€, representing 87.9% of revenue. Warning negative scissor effect: despite revenue change (+66%), EBITDA varies by +59%, reducing margin by 3.8 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 85 k€, i.e. 64.3% of revenue. This profit can be retained or distributed to shareholders.
132 474 €
132 474 €
116 399 €
109 968 €
85 210 €
87.9%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Cash flow represents 69.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
0.0%
69.194%
0.0
70.5%
In 2022, the debt ratio of MED-EYES (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2022, the financial autonomy of MED-EYES (0.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2022, the repayment capacity of MED-EYES (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 511.33. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
511.333
0.0
In 2022, the liquidity ratio of MED-EYES (511.33) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2022, the interest coverage of MED-EYES (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 125 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 3 days. The gap of 122 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 68 days of revenue, i.e. 25 k€ to permanently finance.
24 906 €
125 j
3 j
0 j
68 j
Based on 120 transactions of similar company sales (all years), the value of MED-EYES is estimated at 176 896 € (range 78 178€ - 483 723€). With an EBITDA of 116 399€, the sector multiple of 2.2x is applied. The price/revenue ratio is 0.27x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 120 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MED-EYES with other companies in the same sector:
Voir toutes les statistiques du secteur Programmation informatique
The revenue of MED-EYES in 2022 is 132 k€.
Yes, MED-EYES generated a net profit of 85 k€ in 2022.
The headquarters of MED-EYES is located in MONTPELLIER (34000), in the department Herault.
The tax return of MED-EYES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MED-EYES operates in the sector Programmation informatique (NAF code 62.01Z). See the 'Sector positioning' section above to compare the company with its competitors.